Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells-Reference-Cited by-同舟云学术

Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells

Published:2014-05 Issue:1-2 Volume:152 Page:115-126
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Cunnusamy Khrishen,Baughman Ethan J.,Franco Jorge,Ortega Sterling B.,Sinha Sushmita,Chaudhary Parul,Greenberg Benjamin M.,Frohman Elliot M.,Karandikar Nitin J.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. Epidemiology and natural history of multiple sclerosis: new insights;Kantarci;Curr. Opin. Neurol.,2006

2. Multiple sclerosis;Compston;Lancet,2008

3. Multiple sclerosis: an immune or neurodegenerative disorder?;Trapp;Annu. Rev. Neurosci.,2008

4. Multiple sclerosis: new insights in pathogenesis and novel therapeutics;Ontaneda;Annu. Rev. Med.,2012

5. Immunology of multiple sclerosis;Sospedra;Annu. Rev. Immunol.,2005

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-Bromo-1,4-Naphthalenedione promotes CD8+ T cell expansion and limits Th1/Th17 to mitigate experimental autoimmune encephalomyelitis;Journal of Neuroinflammation;2024-07-27

2. Disruption of IFNγ, GZMB, PRF1, or LYST Results in Reduced Suppressive Function in Human CD8+ T Cells;The Journal of Immunology;2024-04-12

3. The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis;Journal of Immunology Research;2024-01-04

4. Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice;International Immunopharmacology;2023-12

5. IL-17 cytokines preferentially act on naïve CD4+ T cells with the IL-17AF heterodimer inducing the greatest functional changes;PLOS ONE;2023-04-28